EUROPEAN JOURNAL OF INTERNAL MEDICINE, vol.20, no.1, pp.44-47, 2009 (SCI-Expanded)
Background: Familial Mediterranean Fever (FMF) is a systemic relapsing autoinflammatory disorder. Adenosine deaminase (ADA) is an enzyme widely distribute in tissues and body fluids. Circulating levels of ADA have been shown to increase in several inflammatory conditions. This study was designed to evaluate the serum ADA in patients with FMF during acute attacks and attack-free periods.